$94.38
1.90% yesterday
Nasdaq, Aug 12, 10:00 pm CET

LeMaitre Vascular, Inc. Stock price

$94.38
+10.29 12.24% 1M
-1.94 2.01% 6M
+2.24 2.43% YTD
+12.28 14.96% 1Y
+39.60 72.29% 3Y
+65.39 225.56% 5Y
+81.15 613.38% 10Y
+88.18 1,422.26% 20Y
Nasdaq, Closing price Tue, Aug 12 2025
+1.76 1.90%

Key metrics

Basic
Market capitalization
$2.1b
Enterprise Value
$1.9b
Net debt
positive
Cash
$319.5m
Shares outstanding
22.6m
Valuation (TTM | estimate)
P/E
45.0 | 42.2
P/S
8.9 | 8.4
EV/Sales
8.3 | 7.8
EV/FCF
37.2
P/B
5.8
Dividends
DPS
$0.64
Yield 1Y | 5Y
0.7% | 1.0%
Growth 1Y | 5Y
14.3% | 13.5%
Payout 1Y | 3Y
33.2% | 40.5%
Increased
14 Years
Financials (TTM | estimate)
Revenue
$234.6m | $250.4m
EBITDA
$60.5m | $73.8m
EBIT
$54.8m | $59.0m
Net Income
$47.1m | $49.7m
Free Cash Flow
$52.3m
Growth (TTM | estimate)
Revenue
14.1% | 13.9%
EBITDA
17.2% | 27.2%
EBIT
20.0% | 13.0%
Net Income
25.1% | 12.9%
Free Cash Flow
65.2%
Margin (TTM | estimate)
Gross
69.1%
EBITDA
25.8% | 29.5%
EBIT
23.3%
Net
20.1% | 19.9%
Free Cash Flow
22.3%
Financial Health
Equity Ratio
61.1%
Return on Equity
13.1%
ROCE
10.0%
ROIC
16.8%
Debt/Equity
0.5
More
EPS
$2.1
FCF per Share
$2.3
Short interest
8.2%
Employees
658
Rev per Employee
$330.0k
Show more

Is LeMaitre Vascular, Inc. a Top Scorer Stock based on the Dividend, High-Growth-Investing or Leverman Strategy?

As a Free StocksGuide user, you can view scores for all 7,027 stocks worldwide.

LeMaitre Vascular, Inc. Stock Analysis

Unlock Scores for Free

Analyst Opinions

17 Analysts have issued a LeMaitre Vascular, Inc. forecast:

10x Buy
59%
7x Hold
41%

Analyst Opinions

17 Analysts have issued a LeMaitre Vascular, Inc. forecast:

Buy
59%
Hold
41%

Financial data from LeMaitre Vascular, Inc.

Income Statement P&L | Balance Sheet | Cash Flow


Quarter TTM Annually
Jun '25
+/-
%
235 235
14% 14%
100%
- Direct Costs 72 72
9% 9%
31%
162 162
16% 16%
69%
- Selling and Administrative Expenses 87 87
23% 23%
37%
- Research and Development Expense 15 15
12% 12%
6%
60 60
17% 17%
26%
- Depreciation and Amortization 5.70 5.70
5% 5%
2%
EBIT (Operating Income) EBIT 55 55
20% 20%
23%
Net Profit 47 47
25% 25%
20%

In millions USD.

Don't miss a Thing! We will send you all news about LeMaitre Vascular, Inc. directly to your mailbox free of charge.

If you wish, we will send you an e-mail every morning with news on stocks of your portfolios.

LeMaitre Vascular, Inc. Stock News

Positive
The Motley Fool
7 days ago
LeMaitre (LMAT) Q2 Revenue Jumps 15%
Neutral
Seeking Alpha
7 days ago
LeMaitre Vascular, Inc. (NASDAQ:LMAT ) Q2 2025 Earnings Conference Call August 5, 2025 5:00 PM ET Company Participants David B. Roberts - President & Director Dorian LeBlanc - Chief Financial Officer George W.
Neutral
GlobeNewsWire
7 days ago
BURLINGTON, Mass., Aug. 05, 2025 (GLOBE NEWSWIRE) -- LeMaitre Vascular, Inc. (Nasdaq: LMAT), a provider of vascular devices, implants, and services, today reported Q2 2025 results, announced a quarterly dividend of $0.20/share, and provided guidance.
More LeMaitre Vascular, Inc. News

Company Profile

LeMaitre Vascular, Inc. engages in the provision of medical devices and human tissue cryopreservation services. The company focuses on the design, marketing, sales, service, and technical support of medical devices and implants for the treatment of peripheral vascular disease. Its products include balloon catheters, carotid shunts, biologic patches, radiopaque marking tape, anastomotic clips, remote endarterectomy devices, laparoscopic cholecystectomy devices, vascular grafts, and powered phlebectomy. The company was founded by George D. LeMaitre on November 28, 1983 and is headquartered in Burlington, MA.

Head office United States
CEO George LeMaitre
Employees 658
Founded 1983
Website www.lemaitre.com

Register for Free

StocksGuide is the ultimate tool for easily finding, analyzing and tracking stocks. Learn from successful investors and make informed investment decisions. We empower you to become a confident, independent investor.

The Apple stock at a glance with charts, current key metrics, news and stock analyses.
The Best Dividend Stocks in the Dividend Top Scorer list.
Stock Analyses of the Best Stocks Worldwide.
Start building wealth today